Poorya Sabounchi

Cofounder and COO @ixlayer_

[World of Statistics @stats_feed]

Age of countries by ancient origins:

🇮🇷 Iran: 5,226 years
🇪🇬 Egypt: 5,126 years
🇻🇳 Vietnam: 4,905 years
🇦🇲 Armenia: 4,518 years
🇰🇵 North Korea: 4,359 years
🇨🇳 China: 4,096 years
🇮🇳 India: 4,026 years
🇬🇪 Georgia: 3,326 years
🇪🇹 Ethiopia: 3,006 years
🇬🇷 Greece: 2,826 years
🇷🇺 Russia: 2,726 years
🇦🇫 Afghanistan: 2,704 years
🇯🇵 Japan: 2,686 years
🇲🇳 Mongolia: 2,235 years
🇹🇭 Thailand: 1,426 years

[ixlayer @ixlayer_]

https://t.co/Ho7IhInaAu

[ixlayer @ixlayer_]

Patients are voting with their clicks— 86 % have used a digital health tool in the past year, but their top frustration is juggling too many apps that don’t talk to one another .
https://t.co/AeNQaIOcOO

[L.A. Care Health Plan @LACareHealth]

L.A. Care is a finalist in the @FierceHealth #DEIAwards for Outstanding DEI Initiative in Patient Care with our partner @ixlayer_! Our At-Home Diagnostic Program nearly doubled our preventive colorectal cancer, diabetes, and kidney disease screenings rates.📦🩺

https://t.co/Up6oVWnnUI

[ixlayer @ixlayer_]

Honored to share that @ixlayer_ and @sanofi have been named a @PM360online ELITE Marketing, Trade, and Commercial Innovation Team for our work on Screening Central—a bold collaboration that’s redefining what direct-to-consumer programs can look like. https://t.co/l1nWw7JTA6

[ixlayer @ixlayer_]

Almost every pharma marketer and commercialization leader is asking about direct-to-patient platform opportunities. But what do patients want? Thanks to @FiercePharma and the reporting by @andreapark on the ixlayer #ixInsight2025 Study with @Ipsos.
https://t.co/01LDWsYiaK

[ixlayer @ixlayer_]

We are excited to be named to the @DigitalHealthNY 100, joining the ranks of past winners @capsule_health , @mavenclinic , @OscarHealth, @ro , @swordhealth , @Talkiatry , @talkspace and @Zocdoc. Read more in today's press release:

https://t.co/vNkxwBgn1i

[ixlayer @ixlayer_]

Proud to powering Screening Central,@SanofiUS first #telehealth-enabled, user-initiated #T1D autoantibody screening platform, now available across the U.S.
Expanding access to early screening means more #proactivehealth and better #healthoutcomes.

https://t.co/ki5sSMhBK8

[Pear VC @pearvc]

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients.

Congratulations! #HLTHUSA

[Pejman Nozad @pejmannozad]

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients.
Congratulations! #HLTHUSA

[ixlayer @ixlayer_]

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth
https://t.co/YlqlLqAeYY

[ixlayer @ixlayer_]

We’re pleased to announce the launch of ixEngage, our direct-to-patient solution for biopharma that builds on our groundbreaking digital platform that has powered 1,110+ nationwide programs and over 4 million patient care journeys:

https://t.co/HELQG0GLuM

[ixlayer @ixlayer_]

Attending #DPE24? Don’t miss out on our panel discussion, “Leveraging Technology to Improve the Patient Experience and Drive Better Outcomes” featuring insights marketers from @sanofi , @AstraZeneca, @CSLBehring. #DigitalPharmaEast #FiercePharma #DigitalPharma #PharmaMarketing

[ixlayer @ixlayer_]

ixlayer direct-to-patient platform allows biopharma organizations to quickly launch an optimized patient Cx with transparency and control. Our configurable platform enables us to build distinct programs for multiple therapeutic areas within biopharma ecosystem.

[Medical Product Outsourcing @MPOmagazine]

New @ixlayer_ survey shows a large support of at-home diagnostic testing: https://t.co/aoKc4ianuy

[ixlayer @ixlayer_]

NEW IXLAYER PHYSICIAN SURVEY REVEALS OVERWHELMING SUPPORT FOR AT-HOME DIAGNOSTIC TESTING: https://t.co/YFlQnO6lQc

[ixlayer @ixlayer_]

Doctors support growth of at-home testing, survey finds, opening new avenues for biopharma patient outreach https://t.co/2C8NK8WE6t

[ixlayer @ixlayer_]

HCPs show cautious support for at-home diagnostic testing https://t.co/sT0FcOlekw

[MM+M @MMMnews]

Last week at #MMMTransform we heard from panelists from @HealthlineMedia, @ixlayer_, @Verily and
Ubie on the "Techno-empathy and the marketing mix" panel to discuss the evolution of technology in healthcare, emphasizing the importance of prioritizing empathy over efficiency.

[Event World 2026 @magazinesglobal]

event april 2024 -
MM+M Magazine
@MMMnews
Join us for a deep dive into forging human connections through technology at #MMMTransform! 🎤Speakers from: Ubie, Healthline Media, Ixlayer, Verily